top of page


Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions, Synbio Technologies is incorporated with a single mission in mind: to empower scientific discoveries and drug innovation by providing the most advanced and cost-effective DNA technology platform. The company has developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities and has delivered satisfactory solutions globally to researchers for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, etc.

The company’s scientific capabilities cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology work, including but not limited to:

  • Oligo synthesis

  • Gene synthesis

  • Subcloning & PCR cloning

  • Plasmid preparation (up to gram scale)

  • Mutagenesis

  • DNA variant libraries (Permutation, random, trimer libraries, etc.)


  • Protein expression and purification in multiple systems (E.coli, yeast, and mammalian cells)

Relying on its strong DNA sequencing, synthesis, and engineering technology platform, and expertise in bioinformatics analysis, Synbio Tech has developed proprietary algorithms to facilitate and expedite the antibody discovery process. Our antibody discovery services include:

  • Hybridoma sequencing

  • Immune repertoire sequencing

  • Antibody design and production

  • AI-guided heavy chain and light chain pairing

  • Antibody humanization

  • Affinity maturation

  • sdAb (Single Domain Antibody)

The company has over 250 scientific staff and its state of the art production facility is certified with the highest DNA manufacturing standards (ISO9001 & ISO13485).​

bottom of page